Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis

Published:2014-12 Issue:6 Volume:23 Page:721-742
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Molina-Montes Esther,Pérez-Nevot Beatriz,Pollán Marina,Sánchez-Cantalejo Emilio,Espín Jaime,Sánchez María-José

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference68 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Cancer statistics;Siegel;CA A Cancer J Clin,2013

3. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study;De Angelis;Lancet Oncol,2014

4. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972–2001;Soerjomataram;Breast Cancer Res Treat,2005

5. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England;Evans;Br J Cancer,2001

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-02-10

2. A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand: a cost-effective policy in resource-limited settings;Frontiers in Public Health;2023-12-14

3. Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations;Discover Oncology;2023-06-23

4. Clinicopathological analysis of patients with dual malignancies: A retrospective study;Journal of Cancer Research and Therapeutics;2023-05-03

5. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants inATM,BRCA1,BRCA2,CHEK2, andPALB2;Journal of Clinical Oncology;2023-03-20